F-star Therapeutics Inc.

NASDAQ: FSTX · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 08, 2023, 10:00 PM

F-star Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
35.57M 52.96M 68.8M 78.55M 71.05M 81.65M 3.68M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
412K 429K 444K 451K 450K 482K 454K
Receivables
8.14M 7.07M 4.17M 2.31M 1.94M 232K 6.82M
Inventory
n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
5.9M 4.83M 4.32M 3.88M 3.17M 3.44M 3.31M
Total Current Assets
49.61M 64.86M 77.29M 84.74M 76.16M 85.32M 13.8M
Property-Plant & Equipment
3.38M 3.57M 3.78M 4.17M 4.51M 4.92M 5.04M
Goodwill & Intangibles
30.32M 31.78M 33.2M 33.66M 33.67M 34.26M 34.14M
Total Long-Term Assets
34.11M 35.78M 37.42M 38.28M 38.64M 39.66M 39.63M
Total Assets
83.72M 100.64M 114.71M 123.02M 114.8M 124.97M 53.44M
Account Payables
2.5M 4.05M 4.31M 3.08M 1.57M 2.43M 4.08M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
2.14M 1.22M 896K 906K 976K 912K 969K
Other Current Liabilities
10.03M 10.05M 7.45M 8.15M 6.29M 6.61M 9.26M
Total Current Liabilities
14.68M 15.32M 12.65M 12.13M 8.84M 9.95M 14.31M
Long-Term Debt
10.54M 11.64M 12.16M 12.33M 12.41M 12.66M 3.38M
Other Long-Term Liabilities
1.56M 2.05M 1.72M 1.69M 2.9M 2.79M 320K
Total Long-Term Liabilities
12.1M 13.69M 13.89M 14.03M 15.88M 16.03M 4.28M
Total Liabilities
26.78M 29.01M 26.54M 26.16M 24.72M 25.98M 18.6M
Total Debt
12.68M 12.85M 13.05M 13.23M 13.39M 13.57M 4.35M
Common Stock
2K 2K 2K 2K 2K 2K 1K
Retained Earnings
-127.94M -109.53M -90.54M -78.45M -83.19M -72.69M -57.04M
Comprehensive Income
1.56M -692K -1.44M -1.5M -1.14M -1.22M -1.54M
Shareholders Equity
56.94M 71.64M 88.16M 96.86M 90.08M 98.99M 34.84M
Total Investments
n/a n/a n/a n/a n/a n/a n/a